FDA recommendations on BE trials during the pandemic [Regulatives / Guidelines]

posted by Ohlbe – France, 2020-04-28 23:01 (788 d 08:11 ago) – Posting: # 21358
Views: 2,713

Dear all,

The FDA has published high-level recommendations on bioequivalence studies for submission in ANDAs during the COVID-19 pandemic. Basically: it may be a mess outside (no kidding !), prioritise subjects' safety, use controlled correspondence.

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
22,167 posts in 4,645 threads, 1,572 registered users;
online 7 (0 registered, 7 guests [including 2 identified bots]).
Forum time: Sunday 07:12 CEST (Europe/Vienna)

The person interested in success has to learn
to view failure as a healthy, inevitable part
of the process of getting to the top.    Joyce Brothers

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5